Replies to post #13658 on Oncolix Inc. (fka ONCX)

[zen222]

Like I said, stick around and see for yourself. Patience is a virtue.

Upcoming catalysts include:

Uplisting to OTCQB after new ticker.

Major IR/PR push after ticket change/uplist.

Submission of Prolanta™ for Orphan Designation in the European Union.

The company has identified 2 other drugs that they are looking to acquire.

Adding more prestigious board members and a world-class scientific advisory board.

Clinical results relating to Prolanta™.

MD Anderson will soon evaluate Prolanta™ for the treatment of endometrial cancer.

The company is currently pursuing a licensing partner for Prolanta™ in Asia.

Planning for Nasdaq uplist next year.